Fig. 1 · Structure
Documents & Downloads
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol
Lung Carcinogen
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) primarily acts as a lung carcinogen and is a significant metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-related carcinogen. The compound is involved in oxidative metabolic pathways that lead to the formation of NNK and other carcinogenic products. Research applications of NNAL include studies on the molecular mechanisms of lung cancer induction and the effects of tobacco exposure on health.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 76014-81-8 |
| Applications | Lung Carcinogen |
| Formula | C10H15N3O2 |
| Molecular Weight | 209.25 |
| Synonyms | NNAL |
| SMILES | O=NN(CCCC(C1=CC=CN=C1)O)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.